AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Bausch lomb infuse4/24/2023 ![]() ![]() These proprietary ingredients are released during lens wear. The ProBalance Technology™ formula is infused into the lens material during the manufacturing process. © 2020 Bausch & Lomb Incorporated or its affiliates.Bausch + Lomb INFUSE contact lenses feature a next-generation SiHy daily disposable lens material (kalifilcon A) and ProBalance Technology™ that work together to help maintain ocular surface homeostasis to help reduce contact lens dryness and discomfort. ®/TM are trademarks of Bausch & Lomb Incorporated or its affiliates. Bausch Health undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this news release or to reflect actual outcomes, unless required by law. These forward-looking statements speak only as of the date hereof. Readers are cautioned not to place undue reliance on any of these forward-looking statements. They also include, but are not limited to, risks and uncertainties caused by or relating to the evolving COVID-19 pandemic, and the fear of that pandemic and its potential effects, the severity, duration and future impact of which are highly uncertain and cannot be predicted, and which may have a material adverse impact on Bausch Health, including but not limited to its project development timelines, and costs (which may increase). ![]() Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. These risks and uncertainties include, but are not limited to, the risks and uncertainties discussed in Bausch Health's most recent annual report on Form 10-K and detailed from time to time in Bausch Health's other filings with the U.S. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. This news release may contain forward-looking statements, which may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. More information can be found at Forward-looking Statements ![]() We are delivering on our commitments as we build an innovative company dedicated to advancing global health. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. For more information, visit About Bausch Healthīausch Health Companies Inc. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in the industry, which is available in more than 100 countries. Its core businesses include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. We anticipate BAUSCH + LOMB INFUSE will be available to eye care practitioners in the second half of 2020."īausch + Lomb, a leading global eye health business of Bausch Health Companies Inc., is solely focused on helping people see. "We are excited to add this breakthrough new SiHy daily contact lens to our portfolio and provide the outstanding health, vision and comfort that practitioners expect and patients deserve from Bausch + Lomb. "Bausch + Lomb continues to push the innovation curve in the contact lens space with the FDA's clearance of BAUSCH + LOMB INFUSE," said Joe Gordon, U.S. Engineered with Bausch + Lomb's most advanced proprietary contact lens technologies, BAUSCH + LOMB INFUSE offers outstanding breathability for healthy lens wear while providing exceptional all-day comfort and high definition optics. Food and Drug Administration (FDA) for BAUSCH + LOMB INFUSE™ daily disposable silicone hydrogel (SiHy daily) contact lenses.īAUSCH + LOMB INFUSE contact lenses feature a next generation contact lens material (kalifilcon A), which is designed to meet the unmet needs of contact lens wearers, including those who experience contact lens dryness. (NYSE/TSX: BHC) ("Bausch Health"), today announced that it has received 510(k) clearance from the U.S. BRIDGEWATER, N.J., J/PRNewswire/ - Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc.
0 Comments
Read More
Leave a Reply. |